BAY 94-9172 PET/CT in Cognitively Normal Older Adults, Older Adults With Mild Cognitive Impairment, and Older Adults With Alzheimer's Disease
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 31 Mar 2017
At a glance
- Drugs Florbetaben F18 (Primary)
- Indications Alzheimer's disease
- Focus Diagnostic use
- 10 Jun 2017 Biomarkers information updated
- 27 Mar 2017 Planned End Date changed from 1 Jul 2017 to 1 Jul 2018.
- 27 Mar 2017 Planned primary completion date changed from 1 Jan 2017 to 1 Jan 2018.